• G007-LK Tankyrase 1/2 Inhibitor: Mechanism and Research Util

  2026-07-28

  G007-LK is a potent, selective tankyrase 1/2 inhibitor that disrupts Wnt/β-catenin signaling and suppresses tumor growth in APC-mutant colorectal and hepatocellular carcinoma models. Its molecular specificity and robust β-catenin degradation profile make it a key reagent for mechanistic and translational cancer research.

• BI 2536: Precision PLK1 Inhibitor for Cell Cycle Research

  2026-07-28

  BI 2536 stands out as a gold-standard PLK1 inhibitor, enabling researchers to dissect mitotic checkpoint control, G2/M arrest, and apoptosis in cancer models. Its potent nanomolar activity and well-characterized specificity streamline experimental workflows and improve assay reliability.

• CGP 55845 Hydrochloride: Unlocking Astrocyte-GABAB Axis in S

  2026-07-27

  Explore how CGP 55845 hydrochloride, a potent GABAB receptor antagonist, enables next-generation studies of astrocyte-mediated synaptic modulation. This article reveals unique mechanistic insights and protocol guidance for cutting-edge neurotransmission assays.

• p53/PUMA-Dependent Synthetic Lethality in MSI Colorectal Can

  2026-07-27

  The referenced study reveals that inhibition or depletion of Werner (WRN) helicase triggers selective, p53/PUMA-dependent apoptosis in mismatch repair-deficient (MSI) colorectal cancer cells. This mechanistic insight clarifies the molecular vulnerability of p53-wildtype MSI CRCs and supports WRN targeting as a precise therapeutic strategy.

• Peroxynitrite-Induced ER–Mitochondrial Ca2+ Flux Drives Card

  2026-07-26

  Liu et al. elucidate how peroxynitrite exacerbates cardiac microvascular injury in hyperhomocysteinemia by inducing ER stress and pathological Ca2+ signaling, culminating in necroptosis. Their work highlights the IP3R–mitochondrial Ca2+ transfer axis as a tractable therapeutic target, informing both cardiovascular and necroptosis pathway research.

• Indometacin Sodium Trihydrate: Precision Tools for Inflammat

  2026-07-25

  Indometacin Sodium Trihydrate empowers precise modulation of inflammation in both cellular and reproductive models, offering researchers robust, reproducible results. Its multifaceted mechanism—spanning COX inhibition, prostaglandin synthesis suppression, and Wnt/β-catenin pathway modulation—enables advanced experimental design and targeted troubleshooting across applications from IVF to myelin repair.

• Naloxone Hydrochloride: Bench Protocols for Opioid Antagonis

  2026-07-24

  Naloxone hydrochloride enables precise modulation of opioid receptor signaling in both neural and immunological assays, supporting translational research from addiction models to stem cell biology. This guide details workflow optimizations, troubleshooting, and practical innovations—grounded in recent studies—to maximize data reproducibility and mechanistic clarity.

• AS1842856 Foxo1 Inhibitor: Protocols for Metabolic Research

  2026-07-24

  AS1842856 enables precise, reproducible inhibition of Foxo1 in metabolic, stem cell, and autophagy studies, facilitating targeted exploration of gluconeogenesis and bone remodeling pathways. This guide translates cutting-edge mechanistic insights into actionable workflows, troubleshooting strategies, and optimization tips for advanced metabolic research.

• PDGF-BB in Cell Proliferation Assays: Protocols & Innovation

  2026-07-23

  Murine recombinant PDGF-BB is a gold-standard mitogen driving high-fidelity cell proliferation and vascular remodeling assays. Learn how APExBIO's validated PDGF-BB empowers translational workflows, informed by mitochondrial reprogramming research in pulmonary hypertension.

• Novel Allosteric PDK4 Inhibitors for Metabolic Disease Thera

  2026-07-23

  Jeon et al. identified a new series of potent, orally available allosteric inhibitors of pyruvate dehydrogenase kinase 4 (PDK4), with lead compound 8c demonstrating efficacy in improving glucose tolerance, reducing allergic reactions, and exhibiting anticancer activity in preclinical models. These findings provide a novel chemical scaffold for targeting PDK4 in metabolic, allergic, and proliferative diseases.

• BMS 599626 dihydrochloride: Bridging EGFR/ErbB2 Inhibition t

  2026-07-22

  Explore the strategic application of BMS 599626 dihydrochloride in translational oncology, focusing on precise EGFR/ErbB2 inhibition, mechanistic insights, and workflow optimization. This article connects molecular pharmacology to real-world cancer research challenges, incorporates evidence from recent senolytic discovery literature, and offers actionable recommendations for advanced experimental design.

• Fe3O4@ZIF-8 Nanoparticles: Dual Antibiosis & Osteogenesis in

  2026-07-22

  The study introduces Fe3O4@ZIF-8 core–shell nanoparticles that address both persistent infection and bone defect repair in jaw osteomyelitis by combining pH-responsive antibacterial activity with osteogenic potential. This multifunctional nanoplatform offers a promising translational strategy for treating complex oral infections where conventional therapies fall short.

• Sumatriptan Succinate: Advanced 5-HT1 Receptor Agonist Workf

  2026-07-21

  Sumatriptan Succinate, a selective 5-HT1 receptor agonist, is redefining in vitro and in vivo migraine and inflammation research by enabling robust, reproducible modeling of serotonergic pathways. This guide delivers actionable protocols, troubleshooting strategies, and the latest evidence on anti-inflammatory mechanisms, empowering scientists to maximize data quality using APExBIO’s high-purity compound.

• Imatinib Hydrochloride in Cancer Research: Protocols & Pitfa

  2026-07-21

  Imatinib hydrochloride (STI571 hydrochloride) is a multi-target tyrosine kinase inhibitor with proven utility for dissecting oncogenic signaling in chronic myelogenous leukemia and gastrointestinal stromal tumor models. This guide delivers protocol refinements, advanced applications, and troubleshooting strategies grounded in recent mechanistic breakthroughs, enabling superior reproducibility and translational insight.

• PPM-18: Advanced iNOS Inhibition for Sepsis and Inflammation

  2026-07-20

  PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide) delivers targeted NF-κB pathway and iNOS expression inhibition, empowering researchers with precision modulation of inflammatory signaling in both in vitro and in vivo sepsis models. Its robust solubility profile and validated anti-inflammatory performance set it apart as the go-to APExBIO reagent for advanced immune response research.

454 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page